Aspirin is effective in the prevention of cardiovascular events in high-risk patients. The
primary established effect of aspirin on hemostasis is to impair platelet aggregation via …

Acetylsalicylic acid, or aspirin, was synthesized by Hoffmann in 1898. Initially, this simple
chemical compound was used as an antipyretic and anti-inflammatory agent. In the late …

Aspirin is effective in the prevention of cardiovascular events in high-risk patients. The
primary established effect of aspirin on hemostasis is to impair platelet aggregation via …

Aspirin is effective in the prevention of cardiovascular events in high-risk patients. The
primary established effect of aspirin on hemostasis is to impair platelet aggregation via …

Aspirin is effective in the prevention of cardiovascular events in high-risk patients. The
primary established effect of aspirin on hemostasis is to impair platelet aggregation via …

Acetylsalicylic acid, or aspirin, was synthesized by Hoffmann in 1898. Initially, this simple
chemical compound was used as an antipyretic and anti-inflammatory agent. In the late …

Antithrombotic properties of aspirin and resistance to aspirin : beyond strictly antiplatelet
actions CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …

Aspirin is effective in the prevention of cardiovascular events in high-risk patients. The
primary established effect of aspirin on hemostasis is to impair platelet aggregation via …

Aspirin is effective in the prevention of cardiovascular events in high-risk patients. The
primary established effect of aspirin on hemostasis is to impair platelet aggregation via …

Acetylsalicylic acid, or aspirin, was synthesized by Hoffmann in 1898. Initially, this simple
chemical compound was used as an antipyretic and anti-inflammatory agent. In the late …